Pipeline and Commercial Insight: Insomnia - Future of Innovative Orexin Drug Class in Doubt Now Available at ReportsandReports
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market.
View full press release